kleintier konkret, Inhaltsverzeichnis kleintier konkret 2023; 26(05): 39-49DOI: 10.1055/a-2061-3916 CVE-Fortbildung Orthopädie Die Hüftgelenkdysplasie des Hundes – Therapie Carolin Werres Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Zur Behandlung der Hüftgelenkdysplasie existieren eine Vielzahl verschiedener Therapieoptionen. Neben chirurgischen Maßnahmen unterschiedlichen Umfangs nehmen konservative Behandlungsmethoden einen wichtigen Stellenwert ein. Ziel ist es stets, die Mobilität und Lebensqualität der betroffenen Patienten zu verbessern. Volltext Referenzen Literatur 1 Ginja M, Gaspar AR, Ginja C. Emerging insights into the genetic basis of canine hip dysplasia. Vet Med (Auckl) 2015; 6: 193-202 2 King MD. Etiopathogenesis of Canine Hip Dysplasia, Prevalence, and Genetics. Vet Clin North Am Small Anim Pract 2017; 47 (04) 753-767 3 Dycus DL, Levine D, Marcellin-Little DJ. Physical Rehabilitation for the Management of Canine Hip Dysplasia. Vet Clin North Am Small Anim Pract 2017; 47 (04) 823-850 4 Harper TAM. Conservative Management of Hip Dysplasia. Vet Clin North Am Small Anim Pract 2017; 47 (04) 807-821 5 Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc 2000; 216 (07) 1089-1091 6 Kealy RD, Lawler DF, Ballam JM. et al. Evaluation of the effect of limited food consumption on radiographic evidence of osteoarthritis in dogs. J Am Vet Med Assoc 2000; 217 (11) 1678-1680 7 Smith GK, Paster ER, Powers MY. et al. Lifelong diet restriction and radiographic evidence of osteoarthritis of the hip joint in dogs. J Am Vet Med Assoc 2006; 229 (05) 690-693 8 Hielm-Bjorkman A, Roine J, Elo K. et al. An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA. BMC Vet Res 2012; 8: 157 9 Rialland P, Bichot S, Lussier B. et al. Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis. Can J Vet Res 2013; 77 (01) 66-74 10 Lust G, Williams AJ, Burton-Wurster N. et al. Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups. Am J Vet Res 1992; 53 (10) 1836-1843 11 Todhunter RJ, Lust G. Polysulfated glycosaminoglycan in the treatment of osteoarthritis. J Am Vet Med Assoc 1994; 204 (08) 1245-1251 12 Fujiki M, Shineha J, Yamanokuchi K. et al. Effects of treatment with polysulfated glycosaminoglycan on serum cartilage oligomeric matrix protein and C-reactive protein concentrations, serum matrix metalloproteinase-2 and -9 activities, and lameness in dogs with osteoarthritis. Am J Vet Res 2007; 68 (08) 827-833 13 Haan JJ de Goring RL, Beale BS. Evaluation of polysulfated glycosaminoglycan for the treatment of hip dysplasia in dogs. Vet Surg 1994; 23 (03) 177-181 14 Kirkby KA, Lewis DD. Canine hip dysplasia: reviewing the evidence for nonsurgical management. Vet Surg 2012; 41 (01) 2-9 15 Pollmeier M, Toulemonde C, Fleishman C, Hanson PD. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis. Vet Rec 2006; 159 (17) 547-551 16 Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 2003; 152 (11) 323-329 17 Mansa S, Palmer E, Grondahl C. et al. Long-term treatment with carprofen of 805 dogs with osteoarthritis. Vet Rec 2007; 160 (13) 427-430 18 Reymond N, Speranza C, Gruet P. et al. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. J Vet Pharmacol Ther 2012; 35 (02) 175-183 19 Monteiro-Steagall BP, Steagall PV, Lascelles BD. Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs. J Vet Intern Med 2013; 27 (05) 1011-1019 20 Rausch-Derra L, Huebner M, Wofford J, Rhodes L. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis. J Vet Intern Med 2016; 30 (03) 756-763 21 Sartini I, Giorgi M. Grapiprant: A snapshot of the current knowledge. J Vet Pharmacol Ther 2021; 44 (05) 679-688 22 Kong VK, Irwin MG. Gabapentin: a multimodal perioperative drug?. Br J Anaesth 2007; 99 (06) 775-786 23 Di Cesare F, Negro V, Ravasio G. et al. Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses. Animals(Basel) 2023; 13 (12) 2045 24 Corral MJ, Moyaert H, Fernandes T. et al. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis. Vet Anaesth Analg 2021; 48 (06) 943-955 25 Enomoto M, Mantyh PW, Murrell J. et al. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec 2019; 184 (01) 23 26 Krautmann M, Walters R, Cole P. et al. Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs. Vet J 2021; 276: 105733 27 Sharun K, Jambagi K, Dhama K. et al. Therapeutic Potential of Platelet-Rich Plasma in Canine Medicine. Arch Razi Inst 2021; 76 (04) 721-730 28 Cuervo B, Rubio M, Chicharro D. et al. Objective Comparison between Platelet Rich Plasma Alone and in Combination with Physical Therapy in Dogs with Osteoarthritis Caused by Hip Dysplasia. Animals (Basel) 2020; 10 (02) 175 29 Okamoto-Okubo CE, Cassu RN, Joaquim JGF. et al. Chronic pain and gait analysis in dogs with degenerative hip joint disease treated with repeated intra-articular injections of platelet-rich plasma or allogeneic adipose-derived stem cells. J Vet Med Sci 2021; 83 (05) 881-888 30 Black LL, Gaynor J, Gahring D. et al. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 2007; 8 (04) 272-284 31 Ivanovska A, Wang M, Arshaghi TE. et al. Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations. Front Vet Sci 2022; 9: 897150 32 Wits MI, Tobin GC, Silveira MD. et al. Combining canine mesenchymal stromal cells and hyaluronic acid for cartilage repair. Genet Mol Biol 2020; 43 (01) e20190275 33 Vilar JM, Cuervo B, Rubio M. et al. Effect of intraarticular inoculation of mesenchymal stem cells in dogs with hip osteoarthritis by means of objective force platform gait analysis: concordance with numeric subjective scoring scales. BMC Vet Res 2016; 12 (01) 223 34 Sobczak N, Kantyka M. Hirudotherapy in veterinary medicine. Ann Parasitol 2014; 60 (02) 89-92 35 Loeser J, Layer B, Plata C. et al. Hirudotherapy attenuates arthritic pain in patients with various chronic pain syndromes: A retrospective analysis. J Integr Med 2020; 18 (05) 425-433 36 Deisenroth A, Nolte I, Wefstaedt P. Use of gold implants as a treatment of pain related to canine hip dysplasia – a review. Part 2: Clinical trials and case reports. Tierarztl Prax Ausg K Kleintiere Heimtiere 2013; 41 (04) 244-254 37 Hielm-Bjorkman A, Raekallio M, Kuusela E. et al. Double-blind evaluation of implants of gold wire at acupuncture points in the dog as a treatment for osteoarthritis induced by hip dysplasia. Vet Rec 2001; 149 (15) 452-456 38 Jaeger GT, Larsen S, Moe L. Stratification, blinding and placebo effect in a randomized, double blind placebo-controlled clinical trial of gold bead implantation in dogs with hip dysplasia. Acta Vet Scand 2005; 46(1 – 2): 57-68 39 Lie KI, Jaeger G, Nordstoga K, Moe L. Inflammatory response to therapeutic gold bead implantation in canine hip joint osteoarthritis. Vet Pathol 2011; 48 (06) 1118-1124 40 Farrell M, Clements DN, Mellor D. et al. Retrospective evaluation of the long-term outcome of non-surgical management of 74 dogs with clinical hip dysplasia. Vet Rec 2007; 160 (15) 506-511 41 Patricelli AJ, Dueland RT, Adams WM. et al. Juvenile pubic symphysiodesis in dysplastic puppies at 15 and 20 weeks of age. Vet Surg 2002; 31 (05) 435-444 42 Manley PA, Adams WM, Danielson KC. et al. Long-term outcome of juvenile pubic symphysiodesis and triple pelvic osteotomy in dogs with hip dysplasia. J Am Vet Med Assoc 2007; 230 (02) 206-210 43 Dueland RT, Adams WM, Patricelli AJ. et al. Canine hip dysplasia treated by juvenile pubic symphysiodesis. Part I: two year results of computed tomography and distraction index. Vet Comp Orthop Traumatol 2010; 23 (05) 306-317 44 Dueland RT, Patricelli AJ, Adams WM. et al. Canine hip dysplasia treated by juvenile pubic symphysiodesis. Part II: two year clinical results. Vet Comp Orthop Traumatol 2010; 23 (05) 318-325 45 Zhang Z, Zhu L, Sandler J. et al. Estimation of heritabilities, genetic correlations, and breeding values of four traits that collectively define hip dysplasia in dogs. Am J Vet Res 2009; 70 (04) 483-492 46 Slocum B, Slocum TD. Pelvic osteotomy for axial rotation of the acetabular segment in dogs with hip dysplasia. Vet Clin North Am Small Anim Pract 1992; 22 (03) 645-682 47 Borostyankoi F, Rooks RL, Kobluk CN. et al. Results of single-session bilateral triple pelvic osteotomy with an eight-hole iliac bone plate in dogs: 95 cases (1996–1999). J Am Vet Med Assoc 2003; 222 (01) 54-59 48 Rose SA, Bruecker KA, Petersen SW, Uddin N. Use of locking plate and screws for triple pelvic osteotomy. Vet Surg 2012; 41 (01) 114-120 49 Slocum B. Triple pelvic osteotomy. J Am Anim Hosp Assoc 1998; 34 (05) 361-363 50 Vezzoni A, Boiocchi S, Vezzoni L. et al. Double pelvic osteotomy for the treatment of hip dysplasia in young dogs. Vet Comp Orthop Traumatol 2010; 23 (06) 444-452 51 Giebels F, Prescher A, Wagenpfeil S. et al. Nerve distribution and density in the canine hip joint capsule. Comparison of healthy and dysplastic hip joints. Tierarztl Prax Ausg K Kleintiere Heimtiere 2017; 45 (02) 77-83 52 Kinzel S, Hein S, von Scheven C, Kupper W. 10 years experience with denervation of the hip joint capsule for treatment of canine hip joint dysplasia and arthrosis. Berl Munch Tierarztl Wochenschr 2002; 115(1 – 2): 53-56 53 Lister SA, Roush JK, Renberg WC. et al. Ground reaction force analysis of unilateral coxofemoral denervation for the treatment of canine hip dysplasia. Vet Comp Orthop Traumatol 2009; 22 (02) 137-141 54 Off W, Matis U. Excision arthroplasty of the hip joint in dogs and cats. Clinical, radiographic, and gait analysis findings from the Department of Surgery, Veterinary Faculty of the Ludwig-Maximilians-University of Munich, Germany. Vet Comp Orthop Traumatol 2010; 23 (05) 297-305 55 Engstig M, Vesterinen S, Morelius M. et al. Effect of Femoral Head and Neck Osteotomy on Caninesʼ Functional Pelvic Position and Locomotion. Animals (Basel) 2022; 12 (13) 1631 56 Harper TAM. Femoral Head and Neck Excision. Vet Clin North Am Small Anim Pract 2017; 47 (04) 885-897 57 Lippincott CL. Femoral head and neck excision in the management of canine hip dysplasia. Vet Clin North Am Small Anim Pract 1992; 22 (03) 721-737 58 Duff R, Campbell JR. Long term results of excision arthroplasty of the canine hip. Vet Rec 1977; 101 (10) 181-184 59 Fitzpatrick N, Pratola L, Yeadon R. et al. Total hip replacement after failed femoral head and neck excision in two dogs and two cats. Vet Surg 2012; 41 (01) 136-142 60 Olmstead ML. Total hip replacement. Vet Clin North Am Small Anim Pract 1987; 17 (04) 943-955 61 Bergh MS, Gilley RS, Shofer FS, Kapatkin AS. Complications and radiographic findings following cemented total hip replacement: a retrospective evaluation of 97 dogs. Vet Comp Orthop Traumatol 2006; 19 (03) 172-179 62 Fossum TW. Chirurgie der Kleintiere. St. Louis (MO): Elsevier; 2021 63 Hummel DW, Lanz OI, Werre SR. Complications of cementless total hip replacement. A retrospective study of 163 cases. Vet Comp Orthop Traumatol 2010; 23 (06) 424-432 64 Vezzoni L, Vezzoni A, Boudrieau RJ. Long-Term Outcome of Zurich Cementless Total Hip Arthroplasty in 439 Cases. Vet Surg 2015; 44 (08) 921-929 65 Tobias KM, Johnston SA. Veterinary Surgery Small Animal. St. Louis (MO): Elsevier; 2012
